A.J. Rice

Stock Analyst at UBS

(4.28)
# 442
Out of 5,042 analysts
248
Total ratings
64.63%
Success rate
10.61%
Average return

Stocks Rated by A.J. Rice

Service Corporation International
Oct 13, 2025
Maintains: Buy
Price Target: $88$95
Current: $81.67
Upside: +16.32%
BrightSpring Health Services
Oct 13, 2025
Maintains: Buy
Price Target: $31$35
Current: $33.53
Upside: +4.38%
Aveanna Healthcare Holdings
Oct 13, 2025
Maintains: Neutral
Price Target: $8$9
Current: $9.43
Upside: -4.56%
Encompass Health
Oct 2, 2025
Maintains: Buy
Price Target: $140$150
Current: $126.13
Upside: +18.92%
Ardent Health
Sep 10, 2025
Initiates: Buy
Price Target: $17
Current: $15.21
Upside: +11.77%
Elevance Health
Sep 5, 2025
Maintains: Buy
Price Target: $435$425
Current: $342.35
Upside: +24.14%
The Ensign Group
Sep 2, 2025
Maintains: Buy
Price Target: $195$205
Current: $186.05
Upside: +10.19%
Addus HomeCare
Sep 2, 2025
Initiates: Buy
Price Target: $145
Current: $121.63
Upside: +19.21%
Pediatrix Medical Group
Aug 14, 2025
Maintains: Neutral
Price Target: $16$17
Current: $17.60
Upside: -6.25%
Enhabit
Aug 8, 2025
Maintains: Neutral
Price Target: $10$8.5
Current: $8.56
Upside: -0.70%
Maintains: Neutral
Price Target: $15$14
Current: $14.29
Upside: -2.03%
Maintains: Neutral
Price Target: $45$31
Current: $34.07
Upside: -9.01%
Maintains: Neutral
Price Target: $3.5$3.2
Current: $4.10
Upside: -21.95%
Maintains: Buy
Price Target: $230$238
Current: $210.38
Upside: +13.13%
Maintains: Neutral
Price Target: $19$17
Current: $12.96
Upside: +27.31%
Maintains: Neutral
Price Target: $30$26
Current: $21.17
Upside: +20.45%
Maintains: Neutral
Price Target: $80$68
Current: $74.18
Upside: -8.33%
Upgrades: Buy
Price Target: $38$40
Current: $27.91
Upside: +43.32%
Upgrades: Buy
Price Target: $12$15
Current: $18.49
Upside: -18.88%
Initiates: Buy
Price Target: $38
Current: $22.80
Upside: +66.67%
Initiates: Buy
Price Target: $50
Current: $12.66
Upside: +294.94%
Maintains: Buy
Price Target: $247$267
Current: $210.68
Upside: +26.73%
Maintains: Outperform
Price Target: $450$485
Current: $801.67
Upside: -39.50%
Reiterates: Outperform
Price Target: $95
Current: $23.39
Upside: +306.24%
Maintains: Outperform
Price Target: $311$316
Current: $447.04
Upside: -29.31%
Maintains: Outperform
Price Target: $125$96
Current: $81.93
Upside: +17.17%
Maintains: Outperform
Price Target: $635$575
Current: $290.65
Upside: +97.83%
Upgrades: Neutral
Price Target: $38
Current: $28.12
Upside: +35.14%
Maintains: Outperform
Price Target: $590$610
Current: $362.50
Upside: +68.28%
Maintains: Outperform
Price Target: $308$305
Current: $279.49
Upside: +9.13%
Maintains: Neutral
Price Target: $64$79
Current: $161.89
Upside: -51.20%
Maintains: Outperform
Price Target: $350$410
Current: $163.32
Upside: +151.04%
Maintains: Neutral
Price Target: $43$37
Current: $5.51
Upside: +571.51%
Maintains: Neutral
Price Target: $158$143
Current: $182.18
Upside: -21.51%
Maintains: Outperform
Price Target: $300$270
Current: $301.78
Upside: -10.53%
Downgrades: Underperform
Price Target: $0.57
Current: $27.22
Upside: -97.91%